Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Curioni, S.
Right arrow Articles by Cusi, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curioni, S.
Right arrow Articles by Cusi, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 1475-1478
© 2001 European Renal Association-European Dialysis and Transplant Association


Case Report

Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations

Simona Curioni1,2,, Marco D'Amico1,5, Rita Quartagno3, Stefania Martino1,3, Giacomo Dell'Antonio4 and Daniele Cusi1

1 Chair of Nephrology and Graduate School of Nephrology, University of Milan, 2 Division of Nephrology, S. Carlo Borromeo Hospital, 3 Division of Nephrology, Dialysis and Hypertension, S. Raffaele Hospital, 4 Department of Pathology, S. Raffaele Hospital, Milan, and 5 Division of Nephrology, A. Manzoni Hospital, Lecco, Italy

Keywords: AA amyloidosis; autoimmune manifestations; Castleman's disease (hyaline–vascular type); nephrotic syndrome; uveitis; venous thrombosis



   Introduction
 
Castleman's disease (also called giant lymph-node hyperplasia or angiofollicular lymph-node hyperplasia) is a highly heterogeneous clinico-pathological entity belonging to the lympho-proliferative disorders. Originally described in 1956 by Castleman and co-workers [1] as a large, benign, unique asymptomatic mass of mediastinal lymph nodes, it was shown in subsequent reports to include extra-mediastinal and multicentric forms [2].

Two histological patterns of lymph nodes were described: the hyaline–vascular and plasma-cell types. The former is more common (80–90%), and is characterized by the proliferation of capillary vessels in germinal centres of lymphatic folliculi, which assume a hyaline aspect. It is classically reported to have mono-localization, often mediastinal, and a benign course after removal of the mass. The plasma-cell variant is less frequent (10–20%) and presents hyperplastic follicles interspersed by sheets of plasma cells. It is often multi-centric and usually associated with systemic manifestations of inflammatory disease. The prognosis is worse, . . . [Full Text of this Article]



   Case
 


   Discussion
 


   Acknowledgments
 


   Notes
 


   References
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NDT PlusHome page
T. H. Lee, W. Kim, Y. B. Jeong, K. Y. Jang, and S. K. Park
Haematuria and hydronephrosis caused by Castleman's disease
NDT Plus, December 1, 2009; 2(6): 502 - 503.
[Full Text] [PDF]


Home page
QJMHome page
H.J. Lachmann, J.A. Gilbertson, J.D. Gillmore, P.N. Hawkins, and M.B. Pepys
Unicentric Castleman's disease complicated by systemic AA amyloidosis: a curable disease
QJM, April 1, 2002; 95(4): 211 - 218.
[Abstract] [Full Text] [PDF]